Belite Bio (BLTE) Total Liabilities (2021 - 2026)

Belite Bio's Total Liabilities history runs 6 years deep, the most recent figure standing at $15.5 million for Q1 2026.

• On a quarterly basis, Total Liabilities rose 152.54% year-over-year to $15.5 million in Q1 2026; TTM through Mar 2026 was $15.5 million, a 152.54% increase from a year earlier, with the FY2025 full-year figure at $10.1 million, up 59.56% from the prior year.
• Total Liabilities rose to $15.5 million in Q1 2026 per BLTE's latest filing, from $10.1 million in the prior quarter.
• Across five years, Total Liabilities topped out at $15.5 million in Q1 2026 and bottomed at $2.8 million in Q4 2022.
• The 5-year median for Total Liabilities is $4.9 million (2023), against an average of $6.2 million.
• Across the five-year window, Total Liabilities declined 24.63% in 2024 and jumped 152.54% in 2026, its largest moves.
• Year by year, Total Liabilities stood at $2.8 million in 2022, then soared by 51.91% to $4.2 million in 2023, then surged by 49.87% to $6.3 million in 2024, then surged by 59.56% to $10.1 million in 2025, then soared by 53.75% to $15.5 million in 2026.
• Per Business Quant, the three latest BLTE Total Liabilities figures stand at $15.5 million (Q1 2026), $10.1 million (Q4 2025), and $8.3 million (Q3 2025).